title: Interaction of an alpha(+)-thalassemia deletion with either a highly unstable alpha-globin variant (alpha2, codon 59, GGC-->GAC) or a nondeletional alpha-thalassemia mutation (AATAAA-->AATAAG): comparison of phenotypes illustrating "dominant" alpha-thalassemia.
abstract: Thalassemia syndromes and unstable hemoglobins traditionally represent two phenotypically separate disorders of hemoglobin synthesis. Highly unstable hemoglobin variants, however, often have phenotypic characteristics associated with both ineffective erythropoiesis (thalassemias) and peripheral hemolysis (unstable hemoglobins). Many highly unstable beta chain variants cause a dominant thalassemia-like phenotype, in which simple heterozygotes for such mutations have a clinical expression similar to thalassemia intermedia. The phenotypic expression of highly unstable alpha-globin variants is usually less severe, due mainly to a gene dosage effect, and they are often only characterized on interaction with other alpha-thalassemia mutations, whence they are classified as nondeletional alpha-thalassemia determinants. This study reports the clinical and hematological findings in five cases with rare alpha-thalassemia genotypes: a single patient with the thalassemic alpha2-globin gene codon 59 Gly-->Asp hemoglobin variant in trans to an alpha(+)-thalassemia deletion, and four compound heterozygotes for the nondeletional alpha-thalassemia polyadenylation mutation (alpha2 gene AATAAA-->AATAAG or alpha(T-Saudi)alpha/-alpha) and an alpha(+)-thalassemia deletion. Evaluation of the clinical and hematological features in these two analogous genotypes clearly demonstrates the more severe clinical expression associated with the alpha-thalassemic unstable hemoglobin variant. In addition, the case in this study with the codon 59 alpha chain variant provides a further example illustrating the spectrum of phenotypes associated with the alpha-thalassemic hemoglobinopathies.
authors.affiliation: First Department of Pediatrics, University of Athens, St. Sophia 's Children's Hospital, Goudi, Greece.
authors.forename: J
authors.initials: J
authors.lastname: Traeger-Synodinos
authors.forename: A
authors.initials: A
authors.lastname: Metaxotou-Mavrommati
authors.forename: M
authors.initials: M
authors.lastname: Karagiorga
authors.forename: C
authors.initials: C
authors.lastname: Vrettou
authors.forename: I
authors.initials: I
authors.lastname: Papassotiriou
authors.forename: A
authors.initials: A
authors.lastname: Stamoulakatou
authors.forename: E
authors.initials: E
authors.lastname: Kanavakis
mesh_terms: D000293:Adolescent; D002648:Child; D002872:Chromosome Deletion; D003062:Codon; D005260:Female; D005799:Genes, Dominant; D014644:Genetic Variation; D005914:Globins / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D010641:Phenotype; D012333:RNA, Messenger; D017085:alpha-Thalassemia / Q000235:genetics*
chemical_list: D003062:Codon; D012333:RNA, Messenger; D005914:Globins